Three strengths in two bottle sizes make six combinations, and bracketing takes only two of them off the stability schedule.
ICH Q1D (2002) defines bracketing as a stability design in which only samples at the extremes of certain design factors, such as strength, container size or fill, are tested at all time points. The design assumes that the stability of the intermediate levels is represented by the extremes.
Apply that to the six. The lowest and the highest strength go on stability in both bottles, which is four combinations. The middle strength in each bottle is the part bracketed out. The bottle size saves nothing here: with two sizes there is no level between them.
The assumption carries conditions. The guideline says the use of any reduced design should be justified. Where different excipients are used among strengths, bracketing generally should not be applied. And if the two extremes behave differently, the intermediates should be considered no more stable than the least stable extreme.
EU GMP Annex 15 (2015 text) uses the same word in its glossary for process validation batches, with strength, batch size and pack size as the factors.




